Showing results (21-30 of 33) with videos related to
Sort By:
Pageof 4
Oncotarget|June 9, 2015
Ataxia-telangiectasia mutated (ATM) silencing promotes neuroblastoma progression through a MYCN independent mechanismStefano J Mandriota, Linda J Valentijn, Laurence Lesne, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2013
Dual CDK4/CDK6 inhibition induces cell-cycle arrest and senescence in neuroblastomaJulieann Rader, Mike R Russell, Lori S Hart, et al.Nature Communications|September 20, 2017
Common variants in MMP20 at 11q22.2 predispose to 11q deletion and neuroblastoma riskXiao Chang, Yan Zhao, Cuiping Hou, et al.Nature|August 30, 2008
Identification of ALK as a major familial neuroblastoma predisposition geneYaël P Mossé, Marci Laudenslager, Luca Longo, et al.Cancer Research|February 22, 2012
Common variation at BARD1 results in the expression of an oncogenic isoform that influences neuroblastoma susceptibility and oncogenicityKristopher R Bosse, Sharon J Diskin, Kristina A Cole, et al.Nature Genetics|May 5, 2009
Common variations in BARD1 influence susceptibility to high-risk neuroblastomaMario Capasso, Marcella Devoto, Cuiping Hou, et al.The New England Journal of Medicine|May 9, 2008
Chromosome 6p22 locus associated with clinically aggressive neuroblastomaJohn M Maris, Yael P Mosse, Jonathan P Bradfield, et al.Nature|June 19, 2009
Copy number variation at 1q21.1 associated with neuroblastomaSharon J Diskin, Cuiping Hou, Joseph T Glessner, et al.Nature|December 3, 2010
Integrative genomics identifies LMO1 as a neuroblastoma oncogeneKai Wang, Sharon J Diskin, Haitao Zhang, et al.Journal of the National Cancer Institute|March 8, 2018
Genomic Amplifications and Distal 6q Loss: Novel Markers for Poor Survival in High-risk Neuroblastoma PatientsPauline Depuydt, Valentina Boeva, Toby D Hocking, et al.Pageof 4